MAZZOCCHETTI, PETRA
 Distribuzione geografica
Continente #
NA - Nord America 340
EU - Europa 224
AS - Asia 83
Totale 647
Nazione #
US - Stati Uniti d'America 340
IT - Italia 74
IE - Irlanda 66
HK - Hong Kong 34
RO - Romania 29
VN - Vietnam 23
CN - Cina 21
FR - Francia 19
RU - Federazione Russa 9
DE - Germania 6
SE - Svezia 6
FI - Finlandia 5
GB - Regno Unito 4
CH - Svizzera 2
LB - Libano 2
SG - Singapore 2
AT - Austria 1
GR - Grecia 1
RS - Serbia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 647
Città #
Chandler 111
Dublin 66
Perugia 40
Hong Kong 34
Bucharest 27
Redmond 26
Altamura 23
Dong Ket 23
San Mateo 20
Des Moines 15
Lawrence 14
Medford 14
Princeton 14
Andover 11
Beijing 11
Wilmington 11
Los Angeles 6
Falls Church 5
Helsinki 3
Nagold 3
Prato 3
Rome 3
Saint Petersburg 3
Hackney 2
Norwalk 2
San Paolo di Civitate 2
Timisoara 2
Ann Arbor 1
Ashburn 1
Cambridge 1
Fairfield 1
Frankfurt am Main 1
Lappeenranta 1
Ludwigshafen am Rhein 1
Moscow 1
Singapore 1
Totale 503
Nome #
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 101
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 74
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 61
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 58
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 47
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 44
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 42
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease 41
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 38
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 36
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 35
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 34
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 30
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 30
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 28
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits 7
Totale 706
Categoria #
all - tutte 2.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 3 0 0 0 0 3 4 6 3 12 1 3
2020/202178 0 0 2 0 22 6 2 13 4 3 0 26
2021/2022186 3 16 0 2 5 3 1 33 9 46 34 34
2022/2023294 15 61 4 33 22 39 0 18 91 1 7 3
2023/202486 5 12 9 2 1 0 33 0 5 6 13 0
Totale 706